PYXS – pyxis oncology, inc. (US:NASDAQ)
Stock Stats
News
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024 [Yahoo! Finance]
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
Pyxis Oncology to Present at the RBC Capital Markets Global Healthcare Conference
Pyxis Oncology, Inc. (NASDAQ: PYXS) had its "buy" rating re-affirmed by analysts at Jefferies Financial Group Inc.. They now have a $10.00 price target on the stock.
Form 10-Q Pyxis Oncology, Inc. For: Mar 31
Form 8-K Pyxis Oncology, Inc. For: May 14
Form ARS Pyxis Oncology, Inc. For: Dec 31
Form DEF 14A Pyxis Oncology, Inc. For: Jun 11
Form DEFA14A Pyxis Oncology, Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.